|
New research offers reassuring evidence to hundreds of millions of people with high blood pressure that popular anti-hypertension drugs do not put them at greater risk from COVID-19 as some experts had feared. Two blood pressure-lowering drug classes, called ACE inhibitors and ARBs, came under scrutiny after the U.S. Centers for Disease Control and Prevention reported in April that 72 per cent of hospitalized COVID-19 patients 65 or older had hypertension.
|